Loading…

S197: NAVITOCLAX PLUS RUXOLITINIB IN JAK INHIBITOR‐NAÏVE PATIENTS WITH MYELOFIBROSIS: PRELIMINARY SAFETY AND EFFICACY IN A MULTICENTER, OPEN‐LABEL PHASE 2 STUDY

Saved in:

Bibliographic Details
Published in:	HemaSphere 2022-06, Vol.6, p.98-99
Main Authors:	Passamonti, F., Foran, J., Tandra, A., De Stefano, V., Laura Fox, M., Mattour, A., McMullin, M. F., Perkins, A. C., Rodriguez‐Macías, G., Sibai, H., Qin, Q., Potluri, J., How, J.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!